Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of <i>Pseudomonas aeruginosa</i> bacteraemia: new kids on the ICU block?
Davide Fiore Bavaro(Humanitas University), Michele Bartoletti(University of Bologna), Silvia Corcione(University of Turin), Matteo Bassetti(Ospedale Policlinico San Martino), Lucia Diella(Humanitas University), Pierluigi Viale(Azienda USL di Bologna), Simone Mornese Pinna, Giuseppe Accurso(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Maddalena Giannella(Hospital General Universitario Gregorio Marañón), Teresa Fasciana(University of Palermo), Francesco Giuseppe De Rosa(University of Turin), Daniele Roberto Giacobbe(Ospedale Policlinico San Martino), Antonio Vena(Ospedale Policlinico San Martino), Andrea Marıno(University of Catania), Francesca Giovannenze(Agostino Gemelli University Polyclinic), Nicholas Geremia(Ospedale San Paolo), Michela Schenone(Ospedale Policlinico San Martino), Renato Pascale(University of Bologna)
Cited by 10
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998